-- レメジェン（香港証券取引所：9995、上海証券取引所：688331）は、2026年第1四半期に3億2800万元の帰属利益を計上した。これは前年同期の2億5410万元の赤字から黒字転換となる。香港証券取引所への火曜日の提出書類で明らかになった。 このバイオ医薬品会社の香港株は、水曜日の午前中の取引終盤で2%下落した。 1株当たり利益は0.58元で、前年同期の0.46元の赤字から黒字に転換した。 営業収益は前年同期比25%増の6億5620万元となった。
Related Articles
Asia
MOG Digitech Chairman Resigns; Co-CEO Assumes CEO Role
MOG Digitech (HKG:1942) announces Deng Zhihua's resignation as its chairman and co-CEO effective Tuesday.The move allows Mr. Deng to dedicate more time to his other commitments, according to a Tuesday Hong Kong bourse filing.Shares of the fintech company were up 1% in Wednesday afternoon trading.Co-CEO Chen Yongzhong was also appointed as the company's CEO, starting on the same day.The firm is currently in the process of identifying a suitable candidate for the chair position.
$HKG:1942
Asia
Genertec Universal Medical's Profit Rises 5% in Q1
Genertec Universal Medical (HKG:2666) said profit attributable to ordinary shareholders rose about 4.8% year over year in the first quarter, according to a Hong Kong bourse filing.Revenue fell about 4.5% from a year earlier.The group said its integrated healthcare business saw outpatient and emergency visits rise about 4.5% year over year, while health check-up revenue increased about 13.3%.
$HKG:2666
Asia
Jefferies Adjusts The Phoenix Mills' Price Target to INR2,085 from INR2,000, Keeps at Buy
$BOM:503100$NSE:PHOENIXLTD